Shopping Cart 0
Cart Subtotal
AED 0

BioCorRx Inc (BICX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication-assisted treatment (MAT) program that includes a counseling program coupled with its proprietary naltrexone implant. It also develops BICX101, an injectable naltrexone product; and BICX102, an implantable naltrexone implant for the treatment of alcohol and opioid addiction. The company distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. BioCorRx is headquartered in Anaheim, California, the US.

BioCorRx Inc (BICX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

BioCorRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

BioCorRx Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Biocorrx Acquires Portfolio from Therakine Biodelivery 12

BioCorRx Acquires Intellectual Property and Contractual Rights of Well Advised 13

Private Equity 14

Alpine Creek Capital Partners to Invest USD1.66 Million in BioCorRx 14

Partnerships 15

BioCorRx Enters into Licensing Agreement with Therakine 15

BioCorRx to Enter into Agreement with VDM Biochemicals 16

Licensing Agreements 17

BioCorRx Enters into Licensing Agreement with Fresh Start Private Midwest 17

Equity Offering 18

BioCorRx Raises USD1.1 Million in Private Placement of Units 18

Debt Offering 19

BioCorRx Raises USD0.08 Million in Private Placement of Note 19

BioCorRx Raises USD0.08 Million in Private Placement of Note 20

BioCorRx Raises USD0.3 Million in Private Placement of Note 21

BioCorRx Inc-Key Competitors 22

BioCorRx Inc-Key Employees 23

BioCorRx Inc-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Product News 25

07/25/2017: BioCorRx Announces EnLite Clinics to Implement the BioCorRx Recovery Program in Three Clinics in Ohio 25

07/06/2017: BioCorRx to Exhibit at ASAM Conference in Dallas, Texas 26

05/22/2018: BioCorRx Announces Grant Submission to the National Institutes of Health for BICX102 27

04/30/2018: BioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone Implant 28

04/26/2018: BioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company's Sustained Release Naltrexone Implant for Alcohol Use Disorder 29

04/05/2018: BioCorRx Partner, Virtual Reality Medical Center, Submits Small Business Innovation Grant Application to the National Institute of Health 30

01/05/2018: BioCorRx Retains Regulatory Drug Expert Priya Jambhekar and CMC Expert Bruce Firestone 31

01/02/2018: BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic 32

Product Approvals 33

Feb 12, 2018: BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102 33

Dec 19, 2017: BioCorRx Submits Pre-IND Package to FDA for its Naltrexone Implant, BICX102 34

Sep 28, 2017: BioCorRx Announces Update on Commercialization Efforts for Naltrexone Implant 35

Jan 12, 2017: BioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products 36

Other Significant Developments 37

Apr 06, 2018: BioCorRx Provides Business Update for the Full Year Ended 2017 37

Mar 15, 2018: BioCorRx Provides Update on New Weight Management Program 39

Nov 17, 2017: BioCorRx Provides Business Update for the Third Quarter of 2017 40

Sep 12, 2017: BioCorRx Announces Beta Launch of Mobile Application for Opioid and Alcohol Substance Use Disorder 41

Aug 15, 2017: BioCorRx Reports 12% Increase in Revenue and Provides Business Update for the Second Quarter of 2017 42

Jul 31, 2017: Serrano Kidney and Vascular Access Center to Implement the BioCorRx Recovery Program for the Hispanic Market in Los Angeles 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

BioCorRx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

BioCorRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

BioCorRx Inc, Deals By Therapy Area, 2012 to YTD 2018 9

BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Biocorrx Acquires Portfolio from Therakine Biodelivery 12

BioCorRx Acquires Intellectual Property and Contractual Rights of Well Advised 13

Alpine Creek Capital Partners to Invest USD1.66 Million in BioCorRx 14

BioCorRx Enters into Licensing Agreement with Therakine 15

BioCorRx to Enter into Agreement with VDM Biochemicals 16

BioCorRx Enters into Licensing Agreement with Fresh Start Private Midwest 17

BioCorRx Raises USD1.1 Million in Private Placement of Units 18

BioCorRx Raises USD0.08 Million in Private Placement of Note 19

BioCorRx Raises USD0.08 Million in Private Placement of Note 20

BioCorRx Raises USD0.3 Million in Private Placement of Note 21

BioCorRx Inc, Key Competitors 22

BioCorRx Inc, Key Employees 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

BioCorRx Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

BioCorRx Inc (BioCorRx), formerly Fresh Start Private Management Inc, is a healthcare solution provider. The company provides alcoholism and opioid addiction treatment program for use in rehabilitation and treatment centers. It distributes and licenses BioCorRx recovery program, a medication-assisted treatment (MAT) program that includes a counseling program coupled with its proprietary naltrexone implant. It also develops BICX101, an injectable naltrexone product; and BICX102, an implantable naltrexone implant for the treatment of alcohol and opioid addiction. The company distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. BioCorRx is headquartered in Anaheim, California, the US.

BioCorRx Inc (BICX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

BioCorRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

BioCorRx Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Biocorrx Acquires Portfolio from Therakine Biodelivery 12

BioCorRx Acquires Intellectual Property and Contractual Rights of Well Advised 13

Private Equity 14

Alpine Creek Capital Partners to Invest USD1.66 Million in BioCorRx 14

Partnerships 15

BioCorRx Enters into Licensing Agreement with Therakine 15

BioCorRx to Enter into Agreement with VDM Biochemicals 16

Licensing Agreements 17

BioCorRx Enters into Licensing Agreement with Fresh Start Private Midwest 17

Equity Offering 18

BioCorRx Raises USD1.1 Million in Private Placement of Units 18

Debt Offering 19

BioCorRx Raises USD0.08 Million in Private Placement of Note 19

BioCorRx Raises USD0.08 Million in Private Placement of Note 20

BioCorRx Raises USD0.3 Million in Private Placement of Note 21

BioCorRx Inc-Key Competitors 22

BioCorRx Inc-Key Employees 23

BioCorRx Inc-Locations And Subsidiaries 24

Head Office 24

Recent Developments 25

Product News 25

07/25/2017: BioCorRx Announces EnLite Clinics to Implement the BioCorRx Recovery Program in Three Clinics in Ohio 25

07/06/2017: BioCorRx to Exhibit at ASAM Conference in Dallas, Texas 26

05/22/2018: BioCorRx Announces Grant Submission to the National Institutes of Health for BICX102 27

04/30/2018: BioCorRx Gains Additional Media Coverage from Fox Medical Correspondent Who Discusses the Advantages of the Naltrexone Implant 28

04/26/2018: BioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company's Sustained Release Naltrexone Implant for Alcohol Use Disorder 29

04/05/2018: BioCorRx Partner, Virtual Reality Medical Center, Submits Small Business Innovation Grant Application to the National Institute of Health 30

01/05/2018: BioCorRx Retains Regulatory Drug Expert Priya Jambhekar and CMC Expert Bruce Firestone 31

01/02/2018: BioCorRx CEO, Brady Granier, Appears on Fox & Friends to Discuss the Opioid Epidemic 32

Product Approvals 33

Feb 12, 2018: BioCorRx Announces Results of Pre-IND meeting with FDA for Sustained Release Naltrexone Implant, BICX102 33

Dec 19, 2017: BioCorRx Submits Pre-IND Package to FDA for its Naltrexone Implant, BICX102 34

Sep 28, 2017: BioCorRx Announces Update on Commercialization Efforts for Naltrexone Implant 35

Jan 12, 2017: BioCorRx Retains Innovative Science Solutions to Guide FDA Regulatory Process for its Naltrexone Products 36

Other Significant Developments 37

Apr 06, 2018: BioCorRx Provides Business Update for the Full Year Ended 2017 37

Mar 15, 2018: BioCorRx Provides Update on New Weight Management Program 39

Nov 17, 2017: BioCorRx Provides Business Update for the Third Quarter of 2017 40

Sep 12, 2017: BioCorRx Announces Beta Launch of Mobile Application for Opioid and Alcohol Substance Use Disorder 41

Aug 15, 2017: BioCorRx Reports 12% Increase in Revenue and Provides Business Update for the Second Quarter of 2017 42

Jul 31, 2017: Serrano Kidney and Vascular Access Center to Implement the BioCorRx Recovery Program for the Hispanic Market in Los Angeles 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

BioCorRx Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

BioCorRx Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

BioCorRx Inc, Deals By Therapy Area, 2012 to YTD 2018 9

BioCorRx Inc, Medical Devices Deals, 2012 to YTD 2018 10

BioCorRx Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Biocorrx Acquires Portfolio from Therakine Biodelivery 12

BioCorRx Acquires Intellectual Property and Contractual Rights of Well Advised 13

Alpine Creek Capital Partners to Invest USD1.66 Million in BioCorRx 14

BioCorRx Enters into Licensing Agreement with Therakine 15

BioCorRx to Enter into Agreement with VDM Biochemicals 16

BioCorRx Enters into Licensing Agreement with Fresh Start Private Midwest 17

BioCorRx Raises USD1.1 Million in Private Placement of Units 18

BioCorRx Raises USD0.08 Million in Private Placement of Note 19

BioCorRx Raises USD0.08 Million in Private Placement of Note 20

BioCorRx Raises USD0.3 Million in Private Placement of Note 21

BioCorRx Inc, Key Competitors 22

BioCorRx Inc, Key Employees 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

BioCorRx Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.